en
Scientific article
English

Membrane bound COMT isoform is an interfacial enzyme: general mechanism and new drug design paradigm

Published inChemical Communications, vol. 54, no. 28, p. 3440-3443
Publication date2018
Abstract

The enzyme catechol-O-methyltransferase (COMT) has water soluble (S-COMT) and membrane associated (MB-COMT), bitopic, isoforms. Of these MB-COMT is a drug target in relation to the treatment of Parkinson's disease. Using a combination of computational and experimental protocols, we have determined the substrate selection mechanism specific to MB-COMT. We show: (1) substrates with preferred affinity for MB-COMT over S-COMT orient in the membrane in a fashion conducive to catalysis from the membrane surface and (2) binding of COMT to its cofactor ADOMET induces conformational change that drives the catalytic surface of the protein to the membrane surface, where the substrates and Mg2+ ions, required for catalysis, are found. Bioinformatics analysis reveals evidence of this mechanism in other proteins, including several existing drug targets. The development of new COMT inhibitors with preferential affinity for MB-COMT over S-COMT is now possible and insight of broader relevance, into the function of bitopic enzymes, is provided.

Research group
Citation (ISO format)
MAGARKAR, Aniket et al. Membrane bound COMT isoform is an interfacial enzyme: general mechanism and new drug design paradigm. In: Chemical Communications, 2018, vol. 54, n° 28, p. 3440–3443. doi: 10.1039/C8CC00221E
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal1359-7345
306views
0downloads

Technical informations

Creation02/25/2019 7:19:00 PM
First validation02/25/2019 7:19:00 PM
Update time03/15/2023 3:47:47 PM
Status update03/15/2023 3:47:46 PM
Last indexation05/03/2024 7:30:56 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack